FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> RNA | syntheic

Texas scientists expand the range of RNA targets

RNA experts at UT Southwestern have advanced their research into the way synthetic strands of RNA can be used to control gene expression. They already knew that the strands disrupted a mixture of proteins around DNA. Now they conclude that the strands also affect a "promoter region" in front of the gene that plays a key role in activating or inhibiting a gene--a central target in therapeutic discovery work. Their insight reveals a whole new area for drug discovery work.

"Our findings about the underlying mechanisms of RNA-activated gene expression reveal a new and unexpected target for potential drug development," said Dr. David Corey, professor of pharmacology and biochemistry at UT Southwestern. "By demonstrating how small RNAs can be used to recruit proteins to gene promoters, we have provided further evidence that this phenomenon should be in the mainstream of science."

- check out the release
- read the story from News-Medical

Related Articles:
Texas--Top Five Regions Targeting Biotech Companies
Synthetic biology spawns fresh approach to antibiotics
Is synthetic biotechnology the next big thing?


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Research Email Newsletter:
Be the first to comment
More stories about RNA   syntheic  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.